<DOC>
	<DOCNO>NCT01758536</DOCNO>
	<brief_summary>The purpose study determine efficacy Huatuo Zaizao Pills improve neural function life quality patient acute ischemic stroke China .</brief_summary>
	<brief_title>Efficacy Study Huatuo Zaizao Pills Improving Neural Function Acute Ischemic Stroke</brief_title>
	<detailed_description>Huatuo Zaizao Pills pure natural preparation plant origin consist Chuanxiong rhizome , Evodia fruit etc . Most ingredient open reserve National Commission Science Technology State Food Drug Administration . Huatuo Zaizao Pills approve market drug several decade treat prevent cardiovascular cerebrovascular disease sequela . It use symptom induce blood stasis stagnation phlegm-wetness , stroke paralysis , stiffness numbness , deviation eye mouth dysphasia . Based history Huatuo Zaizao Pills treatment cerebral infarction hemorrhagic stroke , investigator perform phase IV , double blind , placebo-controlled , randomized multi-Center clinical trial China determine efficacy Huatuo Zaizao Pills improve neural function life quality patient acute ischemic stroke China . The study design target sample size 1100 patient investigator perform 200 patient first period . Patients randomly assign receive Huatuo Zaizao Pills placebo dose 12g time , twice daily . The investigator hypothesis study might offer base medicine evidence test verify efficacy Huatuo Zaizao Pills improve neural function life quality patient ischemic stroke .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<criteria>Patient must age 18 70 year . Patient must ischemic stroke stroke onset 14th day . Patient must mRS score &lt; 5 enrollment mRS score ≤1 stroke onset . Symptoms image CT ( compute tomography ) MRI ( Magnetic Resonance Imaging ) support diagnosis ischemic stroke . Patient must 4 ≤ NIHSS ≤16 . Patient must Glasgow coma scale ( GCS ) ≥7 . Only patient anterior circulation infarction Oxfordshire Community Stroke Project ( OCSP ) classification atherothrombosis cardioembolism modify TOAST classification accept . Patient must understand willing , able likely comply study requirement . Informed consent must obtain . Patient severe cognitive impairment able give voluntary write informed consent participate study . Maybe comply study requirement able participate study regional social reason . Pregnancy , breast feeding possible pregnancy study . Participating another medicine interference study time least within 3 month , enrol study location . Patient mRS≥5 enrollment . Coma patient GCS &lt; 7 . Patient severe cerebral function impairment cause stroke . Patient dysphagia , Wyatt score ≥2 . Lacunar infarction . Patient accompany systemic disease : gastrointestinal hemorrhage , advance carcinoma , liver malfunction , kidney malfunction , severe dementia mental disorder . Unstable patient receive thrombolytic therapy . Cerebral hemorrhage verify CT MRI . History major operation trauma within 6 week major operation arrangement . Allergic one component study medicine . Receiving study medicine component study medicine within 2 week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>ischemic stroke</keyword>
	<keyword>neural function</keyword>
	<keyword>life quality</keyword>
</DOC>